University of California San Francisco
Give to UCSF<p>Our mature brains may not be so old and inflexible after all. Scientists are discovering that the human brain can improve its performance to counter the consequences of cognitive impairment and even the trauma of stroke-induced brain damage.</p>
<p>UCSF scientists <a href="http://profiles.ucsf.edu/ProfileDetails.aspx?Person=4829993" target="_blank">Anatol Kreitzer</a>, PhD, and <a href="http://profiles.ucsf.edu/ProfileDetails.aspx?Person=5506943" target="_blank">Loren Frank</a>, PhD, have won and will share the prestigious 2011 Young Investigator Award from the Society for Neuroscience. </p>
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.
<p>Three UCSF volunteers are leading a $25-million fundraising campaign to raise funds for brain cancer treatment and research.</p>
<p>The widow of the late Sen. Edward M. Kennedy joined a UCSF panel of caregivers and clinicians who recently explored ways of enhancing the quality of life and care of brain cancer patients.</p>